DEA Extends Prescribing Controlled Substances Via Telehealth For 6 Months

May 11, 2023

The U.S. Drug Enforcement Administration (DEA) is extending the ability for physicians to prescribe controlled substances based on telehealth visits through November 11, 2023. This method had been set to expire when the COVID-19 Public Health Emergency ended today (May 11).  

On March 1, the DEA and the Department of Health and Human Services (HHS), sent out notices of proposed rulemakings (NPRMs) to generate feedback on proposals to continue allowing the prescribing of controlled medications via virtual visits with patients. More than 38,000 public comments came in.  

“These medications, including those used to treat opioid use disorder, are a vital form of care for millions of Americans who have come to rely on safe and effective telemedicine appointments,” said the AMA in a statement. “Patients being treated with these medications often have challenges securing and traveling to in-person appointments.” 

Latest News

Free Perinatal Education ECHO Series Now Available

May 21, 2026

The Minnesota Perinatal Quality Collaborative (MNPQC) is offering a free, virtual ECHO series on perinatal education.

First Cohort of Medical School Students Celebrated in St. Cloud

May 21, 2026

As a salute to the inaugural class of the University of Minnesota Medical School CentraCare Regional Campus St. Cloud, the MMA held an open house on May 18 at its Board Chair’s home in Sartell. 

MMA and More Than 400 Orgs Urge Federal Funding for Gun Violence Prevention Research

May 21, 2026

The MMA signed onto a letter to Congress’ Committee on Appropriations on May 18 urging leaders to include funding in the 2027 budget for gun violence prevention research.